Contents

Search

BMS-790052

Indications: - hepatitis C infection Dosage: - 100 mg PO single dose Mechanism of action: - small molecule inhibitor of the HCV NS5A protein

General

antiviral agent

References

  1. Gao M et al. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 2010 May 6; 465:96. PMID: 20410884 - Murray CL et al. An unsuspected drug target. Nature 2010 May 6; 465:42. PMID: 20445618